NIH supports discovery of in vivo chemical probes for novel brain targets, with applicants expected to have validated starting compounds and bioassays; clinical trials are not allowed.
This grant funds early stage trials of new drugs and neuromodulatory devices for psychiatric disorders, aiming to de-risk and attract further funding.
Supports investigator-initiated clinical trials for neurological disorders, from early exploratory studies to Phase 3 confirmatory and comparative effectiveness trials.
Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.
Funding for Alzheimer's drug development from pre-clinical to Phase I clinical trials to prevent, slow, or treat AD symptoms, excluding basic research and non-pharmacological interventions.
NIH supports exploratory research and feasibility planning using invasive recording and stimulation in the human brain to study neural activity and behavior; clinical trials are not allowed.